Niu, J., Luo, H., Chen, W., Li, M., Yan, Y., Cao, L., Ke, L., Wu, S., Xu, H., He, Y. (2026). Intermittent fruquintinib plus trifluridine/tipiracil in refractory metastatic colorectal cancer (mCRC): A single-center, single-arm phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15560